$GERN Recent News Baker Hughes, Halliburton gain on

New Post Public Reply Private Reply Replies (0) Message Board

Dec 7, 2014 at 11:51 PM

$GERN Recent News

Baker Hughes, Halliburton gain on potential merger; Fossil in red 10:07 a.m. Nov. 14, 2014 - Sue Chang
Looming $40 crude and how to vape your way to profits 5:47 a.m. Nov. 14, 2014 - Shawn Langlois
Baker Hughes shares rise on possible buyout 6:02 p.m. Nov. 13, 2014 - Wallace Witkowski
Herbalife shares drop after hours as earnings disappoint 6:58 p.m. Nov. 3, 2014 - Wallace Witkowski
Geron's stock soars after FDA lifts hold on new drug application 7:48 a.m. Nov. 3, 2014 - Tomi Kilgore
Geron's stock jumps 35% premarket after FDA lifts hold on new drug application 7:35 a.m. Nov. 3, 2014 - Tomi Kilgore
FDA places hold on Geren's Imetelstat application 7:25 a.m. March 12, 2014 - MarketWatch.com
Charting the latest market whipsaw 10:59 a.m. Nov. 11, 2013 - Michael Ashbaugh
Oracle active, Geron shares fall after hours 6:06 p.m. Dec. 3, 2012 - Carla Mozee
Geron to discontinue brain-cancer drug development 4:38 p.m. Dec. 3, 2012 - MarketWatch.com
BioTime offers equity stake for Geron assets 8:47 a.m. Oct. 18, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 1:42 p.m. Sept. 10, 2012 - MarketWatch
Geron ends breast cancer study of Imetelstat 7:06 a.m. Sept. 10, 2012 - MarketWatch.com
Stocks to Watch Friday: Splunk, Zumiez, Pandora 3:59 p.m. Aug. 30, 2012 - David B. Wilkerson
Thursday’s biggest gaining and declining stocks 3:31 p.m. Aug. 30, 2012 - MarketWatch
Geron climbs 11% on analyst rating 9:56 a.m. Aug. 30, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:37 p.m. Nov. 15, 2011 - Kate Gibson
Financial uncertainty nixed Geron stem cell work 2:09 p.m. Nov. 15, 2011 - MarketWatch.com
Stocks to watch Friday: Global Crossing, Clarcor 5:42 a.m. Sept. 30, 2011 - MarketWatch
Court upholds stem-cell research funding: reports 10:46 a.m. July 27, 2011 - Val Brickates Kennedy

Geron (GERN) Stock: Moving Average Crossover Alert - Tale of the Tape 9:47 a.m. Dec. 5, 2014 - Zacks.com
BioTime Harnesses Geron's Stem Cell Technology And Its Founder; Is That Enough To Survive The Biotech Revolution? 10:51 a.m. Dec. 3, 2014 - Seeking Alpha
Geron (GERN) Showing Signs Of A Dead Cat Bounce Today 10:10 a.m. Nov. 26, 2014 - TheStreet.com
Strong On High Relative Volume: Geron (GERN) 10:01 a.m. Nov. 21, 2014 - TheStreet.com
Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog 11:23 a.m. Nov. 19, 2014 - Zacks.com
Can the Rally in Geron (GERN) Shares Continue? - Tale of the Tape 8:43 a.m. Nov. 19, 2014 - Zacks.com
Incyte Building Blockbuster Drug One Disease At A Time 2:58 p.m. Nov. 17, 2014 - Investors Business Daily
Geron (GERN) Stock Surges Following Johnson & Johnson Licensing Deal 10:40 a.m. Nov. 17, 2014 - TheStreet.com
Strength Seen in Geron (GERN): Stock Surges 19.5% - Tale of the Tape 9:25 a.m. Nov. 17, 2014 - Zacks.com
Geron Collaborates with J&J for Imetelstat - Analyst Blog 6:00 p.m. Nov. 14, 2014 - Zacks.com
Geron's Short Squeeze Is Here 3:40 p.m. Nov. 14, 2014 - Seeking Alpha
Stock Market Today: Stocks Mixed as Retail Sales Climb, House OKs Keystone Pipeline 3:36 p.m. Nov. 14, 2014 - TheStreet.com
Midday Gainers From November 14: Geron, Pandora Media, Bitauto, IAMGOLD 11:44 a.m. Nov. 14, 2014 - benzinga.com
What Licensing Imetelstat Will Mean for Geron 10:45 a.m. Nov. 14, 2014 - 247WallSt.com
Geron (GERN) Is Today's Pre-Market Mover With Heavy Volume Stock 9:04 a.m. Nov. 14, 2014 - TheStreet.com
Morning Market Movers 8:39 a.m. Nov. 14, 2014 - benzinga.com
Benzinga's Top #PreMarket Gainers 7:03 a.m. Nov. 14, 2014 - benzinga.com
Geron wins deal to develop blood disorder drug, could get $935M 5:55 p.m. Nov. 13, 2014 - Seeking Alpha
Geron Licenses Experimental Myelofibrosis Drug to Johnson & Johnson 4:34 p.m. Nov. 13, 2014 - TheStreet.com
Geron's Risk/Reward Profile Improves As Near-Term Uncertainty Ends 1:06 p.m. Nov. 7, 2014 - Seeking Alpha

Geron to Host Analyst and Investor Meeting on December 8 9:31 p.m. Dec. 5, 2014 - Thomson Reuters ONE
Geron Announces Publication of Preclinical Data on Imetelstat Activity in Acute Myelogenous Leukemia 4:16 p.m. Dec. 4, 2014 - Thomson Reuters ONE
Geron to Present at the 26th Annual Piper Jaffray Healthcare Conference 4:16 p.m. Nov. 26, 2014 - Thomson Reuters ONE
Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 9:00 a.m. Nov. 18, 2014 - PR Newswire - PRF
Geron to Present at the Stifel Healthcare Conference 4:16 p.m. Nov. 14, 2014 - Thomson Reuters ONE
Geron Announces Global Strategic Collaboration with Janssen to Develop and Commercialize Imetelstat 4:16 p.m. Nov. 13, 2014 - Thomson Reuters ONE
Geron Announces Presentations at American Society of Hematology Annual Meeting 9:15 a.m. Nov. 6, 2014 - Thomson Reuters ONE
Geron Announces Removal of Full Clinical Hold on Imetelstat IND 7:31 a.m. Nov. 3, 2014 - Thomson Reuters ONE
Biotech Equities Technical Analysis - ARIAD Pharma, Novavax, Galena Biopharma, Geron, and Celldex Therapeutics 7:40 a.m. Oct. 15, 2014 - PR Newswire - PRF
GERON SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors In Geron Corporation's January 2014 Offering To Contact The Firm 3:00 p.m. Oct. 10, 2014 - PR Newswire - PRF
Biotech Equities Technical Review -- Celldex Therapeutics, Synthetic Biologics, Geron, Catalyst Pharmaceutical Partners, and NPS Pharmaceuticals 8:15 a.m. Sept. 8, 2014 - PR Newswire - PRF
Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 6:00 a.m. Aug. 21, 2014 - PR Newswire - PRF
Geron Corporation Reports Second Quarter 2014 Financial Results 3:06 p.m. Aug. 11, 2014 - Thomson Reuters ONE
Geron to Assume Sponsorship of Myelofibrosis IST and IND 6:30 a.m. Aug. 5, 2014 - Thomson Reuters ONE
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 8:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Geron Announces Conference Call to Discuss Second Quarter 2014 Financial Results 6:31 a.m. July 30, 2014 - Thomson Reuters ONE
Stock Watchout on Biotech Industry -- Research on ARIAD Pharma, Geron, Seattle Genetics, and Sarepta Therapeutics 6:30 a.m. June 26, 2014 - PR Newswire - PRF
Sales, Clinical Hold Removal, Trial Initiations, and Committee Recommendations - Analyst Notes on Geron, Zalicus, Northwest Biotherapeutics, Progenics and TG Therapeutics 4:30 a.m. June 17, 2014 - PR Newswire - PRF
Geron Reports Removal of Partial Clinical Hold on Myelofibrosis IST 4:01 a.m. June 12, 2014 - Thomson Reuters ONE
Intersect ENT Announces Appointment of Chief Financial Officer Jeryl Hilleman 7:03 a.m. June 4, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Eyepic 2-in-1 Camera Innovates at IFA 2026

Call me a sucker for new tech but what Hohem just unveiled might flip content creation on its head. Welcome the Eyepic—a 2-in-1 pocket gimbal camera stirring things up at IFA 2026 in Berlin. Now, maybe your eyeballs are glazing over with all the camera announcements flooding the market. I get it. Yet, this gadget isn’t just another add-on; it's a sneaky move by Hohem...

USF Law Innovators: Leading AI Integration in Academics

Revolutionizing Legal Academia with AI If there's one thing that's caught my eye in the realm of education, it's how some folks over at the University of San Francisco School of Law are shaking things up. These legal eagles aren't messing around with the usual, archaic ways of teaching the law. Nope, they've dove headfirst into the future by hooking their curriculum to...

Curve Memberships: A New Path for Dental Practices

Revolutionizing Dental Practice Management Ever met a dentist who says they love dealing with insurance bureaucracies? Yeah, me neither. Curve Dental's latest gambit into membership plans is aiming to slice right through that mess. They've launched a shiny new component aptly named Curve Memberships. This isn't just some fly-by-night addon; it's about deep...

APX Bridges Crypto & Traditional Finance With New Credit Line

The Future of Financial Bridging Now here's a scenario that might perk your ears up if you've ever toyed with digital assets: APX Lending is stepping up its game, bringing a regulated five-year revolving line of credit backed by Bitcoin and Ethereum to the world stage. It's like blending your grandma's tried-and-true savings approach with the whiz-bang allure of crypto. A...

California American Water’s $8.6M Project: Big Move Upfront

California's Lincoln Oaks neighborhood is gearing up for some necessary upheaval, thanks to California American Water’s new $8.6 million infrastructure overhaul. For decades, those folks in Sylvan Park have been juggling with the roulette of aging water mains in their backyards. Now, imagine that: backyard pipes begging to turn traitors. It's about time someone decided...

Hello Group Posts Q2 Earnings with Mixed Signals

Q2 Revenue Slump Amid Profit Recovery No sugarcoating it, revenue numbers for Hello Group Inc. (NASDAQ:MOMO) are less than stellar for the second quarter of 2026. Net revenues fell 5.1% year-over-year to RMB2,486.0 million (about $366.4 million). Not exactly what you want to see in a growth-oriented tech company. However, what’s really worth your attention is the net...

Innovation Drives New Asia-Pacific Opportunities

A Glimpse Into The Future: Asia-Pacific's Tech Landscape There's a unique transformation bubbling across the Asia-Pacific scene, with young minds pushing the envelope on technology and innovation. Take Nathapol's team from Thailand, for example. They're merging bionic tech with drones for disaster relief—bold, ambitious, and nearly clinching glory at the Lancang-Mekong...

Doug Larson Takes Helm at Integra Pool Covers

A Seasoned Pro Joins Integra Pool Covers Change is afoot over at Explore Industries. They just tapped Doug Larson to be the General Manager for their Integra Pool Covers division. Now, I've seen plenty of hiring announcements in my day, but this has got an interesting ring to it. With Doug on this ship, it's like bringing a wolf back to the wild. Larson's no stranger to...

Curaleaf Eyes Growth: Conference Signals Opportunities

Curaleaf's Strategic Move: Getting in Front of Investors Here comes Curaleaf Holdings, stepping into the spotlight with their eye on increasing investor engagement. Announcing their participation in the ATB Cormark Capital Markets 2026 Fall Institutional Investor Conference, the folks at Curaleaf aren't just talking—they're putting their top brass under the lights. You...

Smithfield's Foreign Lobbying Interests Unveiled Amid Uproar

A Behind-the-Scenes Drama Over Lobbying Disclosure Something's fishy beneath the surface of Smithfield Foods' recent lobbying debacle. The Center for Responsible Food Business (CRFB) has turned the spotlight on some shady practices, and folks, it ain't pretty. Smithfield's lobbyists had been ducking disclosure rules apparently meant to keep track of foreign influence. Who...